drugset / Trial / NCT04884308

Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections

NCT04884308 ↗

Non-randomizedParallel-groupOpen-labelPrevention

Summary

This is pilot study of the immunologic effects of intradermal Bacille Calmette-Guerin (BCG) vaccination of adults with cystic fibrosis (CF), non-CF bronchiectasis (NCFB), and healthy volunteers.

Timeline

Start
2021-04-28
Primary completion
2023-12-30
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject BCG TICE Vaccine Vaccine — Other